These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12169378)

  • 1. Clinicians' perception of sonogram indication for mifepristone abortion up to 63 days.
    Fielding SL; Schaff EA; Nam NY
    Contraception; 2002 Jul; 66(1):27-31. PubMed ID: 12169378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone and misoprostol for early abortion when no gestational sac is present.
    Schaff EA; Fielding SL; Eisinger S; Stadalius L
    Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
    Schaff EA; Fielding SL; Westhoff C
    Contraception; 2001 Aug; 64(2):81-5. PubMed ID: 11704083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
    Rossi B; Creinin MD; Meyn LA
    Contraception; 2004 Oct; 70(4):313-7. PubMed ID: 15451336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical induced abortion].
    Bettahar K; Pinton A; Boisramé T; Cavillon V; Wylomanski S; Nisand I; Hassoun D
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1490-1514. PubMed ID: 27818118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
    Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
    Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion.
    Creinin MD; Spitz IM
    Am J Obstet Gynecol; 1999 Dec; 181(6):1419-24. PubMed ID: 10601923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
    Fox MC; Creinin MD; Harwood B
    Contraception; 2002 Oct; 66(4):225-9. PubMed ID: 12413616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.
    Kapp N; Baldwin MK; Rodriguez MI
    Contraception; 2018 Feb; 97(2):90-99. PubMed ID: 28935220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
    Schaff EA; Fielding SL; Westhoff C
    Contraception; 2002 Oct; 66(4):247-50. PubMed ID: 12413620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of telephone follow-up after medical abortion.
    Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
    Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS; Creinin MD; Harwood B; Schreiber C
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.